venlafaxin "pharmathen" 150 mg depotkapsler, hårde
pharmathen s.a. - venlafaxinhydrochlorid - depotkapsler, hårde - 150 mg
venlafaxin "pharmathen" 75 mg depotkapsler, hårde
pharmathen s.a. - venlafaxinhydrochlorid - depotkapsler, hårde - 75 mg
nitisinone "dipharma" 20 mg kapsler, hårde
dipharma arzneimittel gmbh - nitisinon - kapsler, hårde - 20 mg
strattera 100 mg kapsler, hårde
europharma.dk aps - atomoxetinhydrochlorid - kapsler, hårde - 100 mg
isotretinoin "orion" 20 mg kapsler, bløde
pharmathen s.a. - isotretinoin - kapsler, bløde - 20 mg
strattera 80 mg kapsler, hårde
europharma.dk aps - atomoxetinhydrochlorid - kapsler, hårde - 80 mg
epoprostenol "campuspharma" 500 mikrogram pulver og solvens til infusionsvæske, opløsning
campuspharma ab - epoprostenolnatrium - pulver og solvens til infusionsvæske, opløsning - 500 mikrogram
venlafaxin "pharmathen" 37,5 mg depotkapsler, hårde
pharmathen s.a. - venlafaxinhydrochlorid - depotkapsler, hårde - 37,5 mg
sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin dihydrochlorid - phenylketonurias - andre alimentary tract and metabolism produkter, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
elvanse 50 mg kapsler, hårde
2care4 aps - lisdexamfetamindimesilat - kapsler, hårde - 50 mg